Trials / Completed
CompletedNCT03433768
Androgen Receptor mRNA Expression is Positively Associated With Live Birth in Women Undergoing IVF Independently of the Type of Ovarian Response
Androgen Receptor (AR) mRNA Expression is Positively Associated With Live Birth in Women Undergoing In-vitro Fertilization Independently of the Type of Ovarian Response
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 67 (actual)
- Sponsor
- Aristotle University Of Thessaloniki · Academic / Other
- Sex
- Female
- Age
- 20 Years – 42 Years
- Healthy volunteers
- —
Summary
AR is a steroid hormone receptor that regulates various genes' expression and affects cellular proliferation and differentiation. Androgens interact with AR, exert their paracrine action on granulosa cells and regulate gonadotropin synthesis, follicle development, oocyte maturation and corpus luteum function. Estrogens increase AR mRNA and testosterone binding site in uterine endometrium and leiomyoma. In human cancer cells, low estradiol increases AR levels, suggesting the estrogen/androgen ratio as a predictor of sex steroid response. AR mRNA expression is, also, regulated by progesterone. Although AR mRNA is expressed in the female reproductive tissues, its expression has never been studied in peripheral blood.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | Real time PCR | We take peripheral blood sample at day one, six and ten of ovarian stimulation and measure mRNA expression of androgen receptor. |
Timeline
- Start date
- 2014-09-14
- Primary completion
- 2017-10-10
- Completion
- 2018-01-10
- First posted
- 2018-02-15
- Last updated
- 2018-02-15
Source: ClinicalTrials.gov record NCT03433768. Inclusion in this directory is not an endorsement.